SCHEMBL17847647

SCHEMBL17847647

Cc1c(OS(=O)(=O)C(F)(F)F)c2ccccc2oc1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.48
MAOB P27338 1/20 0.43
CA12 O43570 1/20 0.42
CA9 Q16790 1/20 0.42
MAPT P10636 2/20 0.41
HSD11B1 P28845 1/20 0.41
CYP2C9 P11712 3/20 0.40
HSD17B10 Q99714 2/20 0.40
HPGD P15428 1/20 0.39
STS P08842 1/20 0.38
CYP1A2 P05177 1/20 0.38
GLA P06280 1/20 0.38
MEN1 O00255 1/20 0.38
CYP3A4 P08684 1/20 0.38
PKM P14618 1/20 0.38
RECQL P46063 1/20 0.38
KMT2A Q03164 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
ALDH2 P05091 1/20 0.38
ALPL P05186 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2988102 0.83 HSD17B10 (0.52) KDM4ECA12CA9MAPTHSD11B1
SCHEMBL14701608 0.76 TTR (0.47) KDM4EMAPTHSD17B10HPGDGLA
SCHEMBL6590063 0.75 HSD11B1 (0.40) KDM4EMAOBCA12CA9HSD11B1
SCHEMBL10847170 0.73 HPGD (0.72) MAOBHSD11B1HPGDSTSALPL
SCHEMBL2865145 0.72 KDM4E (0.34) KDM4EMAPTHSD11B1CYP2C9HSD17B10
SCHEMBL8468363 0.72 TNKS (0.47) KDM4EMAOBCA12CA9MAPT
SCHEMBL29072186 0.72 KDM4E (0.54) KDM4ECA12CA9MAPTCYP2C9
SCHEMBL12986005 0.71 KCNA3 (0.51) MAOBCA12CA9MEN1KMT2A
SCHEMBL2450078 0.71 KDM4E (0.71) KDM4EMAOBCA12CA9MAPT
SCHEMBL30629196 0.70 ALDH1A1 (0.62) KDM4EMAOBCA12MAPTHSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10369130-B2 Antibacterial compounds AZIEN DE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. (IT) 2019-08-06 US disclosed
US-10369130-B2 Antibacterial compounds AZIEN DE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. (IT) 2019-08-06 US disclosed
US-20170368017-A1 ANTIBACTERIAL COMPOUNDS AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) 2017-12-28 US disclosed
US-20170368017-A1 ANTIBACTERIAL COMPOUNDS AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) 2017-12-28 US disclosed
EP-3233826-A1 NEW ANTIBACTERIAL COMPOUNDS Aziende Chimiche Riunite Angelini Francesco A.C.R. (IT) 2017-10-25 EP disclosed
WO-2016096631-A1 NEW ANTIBACTERIAL COMPOUNDS AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) 2016-06-23 WO disclosed
WO-2016096631-A1 NEW ANTIBACTERIAL COMPOUNDS AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) 2016-06-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10369130-B2 Antibacterial compounds MRPL21, CLPP, NRDC KDM4E 4034/4885MAOB 2780/4885CA12 4771/4885
US-20170368017-A1 ANTIBACTERIAL COMPOUNDS MRPL21, CLPP, NRDC KDM4E 4034/4885MAOB 2780/4885CA12 4771/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.